STOCK TITAN
  1. Home
  2. Sec-filings
  3. PFE
  4. [Form 4] Pfizer Inc. Insider Trading Activity

[Form 4] Pfizer Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock PFE logo
Pfizer

NYSE:PFE

PFE Rankings

#107 Ranked by Market Cap
#425 Ranked by Dividends

PFE Latest News

Jul 17, 2025
Bristol Myers Squibb and Pfizer Announce Direct-to-Patient Eliquis® (apixaban) Option
Jul 14, 2025
ViiV Healthcare data show 89% of treatment-naïve people with HIV choose to switch to long-acting injectable Vocabria + Rekambys from daily pills after achieving rapid viral suppression
Jul 14, 2025
ViiV Healthcare extends voluntary licensing agreement with Medicines Patent Pool to enable access to innovative long-acting injectable HIV treatment
Jul 10, 2025
XTANDI® Plus Leuprolide Significantly Improves Survival Outcomes in Men with Non-Metastatic Hormone-Sensitive Prostate Cancer with High-Risk Biochemical Recurrence
Jul 8, 2025
ViiV Healthcare presents new data demonstrating positive real-world impact of its innovative long-acting injectables for HIV at IAS 2025

PFE Latest SEC Filings

Jul 2, 2025
[Form 4] Pfizer Inc. Insider Trading Activity
Jul 2, 2025
[Form 4] Pfizer Inc. Insider Trading Activity
Jul 2, 2025
[Form 4] Pfizer Inc. Insider Trading Activity
Jul 2, 2025
[Form 4] Pfizer Inc. Insider Trading Activity
Jul 2, 2025
[Form 4] Pfizer Inc. Insider Trading Activity

PFE Stock Data

146.57B
5.68B
0.06%
67.49%
1.68%
Drug Manufacturers - General
Pharmaceutical Preparations
Link
United States
NEW YORK